IL121525A0 - Process for preparing optically active benzothiazepine compound and intermediate therefor - Google Patents

Process for preparing optically active benzothiazepine compound and intermediate therefor

Info

Publication number
IL121525A0
IL121525A0 IL12152597A IL12152597A IL121525A0 IL 121525 A0 IL121525 A0 IL 121525A0 IL 12152597 A IL12152597 A IL 12152597A IL 12152597 A IL12152597 A IL 12152597A IL 121525 A0 IL121525 A0 IL 121525A0
Authority
IL
Israel
Prior art keywords
optically active
preparing optically
intermediate therefor
benzothiazepine compound
active benzothiazepine
Prior art date
Application number
IL12152597A
Other languages
English (en)
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of IL121525A0 publication Critical patent/IL121525A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12152597A 1996-08-26 1997-08-12 Process for preparing optically active benzothiazepine compound and intermediate therefor IL121525A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22352396 1996-08-26

Publications (1)

Publication Number Publication Date
IL121525A0 true IL121525A0 (en) 1998-02-08

Family

ID=16799485

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12152597A IL121525A0 (en) 1996-08-26 1997-08-12 Process for preparing optically active benzothiazepine compound and intermediate therefor

Country Status (6)

Country Link
US (1) US5945533A (xx)
EP (1) EP0826678A1 (xx)
KR (1) KR19980019025A (xx)
CN (1) CN1174837A (xx)
ID (1) ID18081A (xx)
IL (1) IL121525A0 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS56990B1 (sr) * 2007-09-10 2018-05-31 Janssen Pharmaceutica Nv Postupak za dobijanje jedinjenja koja su korisna kao inhibitori sglt
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
PT2451797E (pt) 2009-07-10 2013-06-25 Janssen Pharmaceutica Nv Processo de cristalização para o 1-(β-d-glucopiranosilo)-4-metilo-3-[5-(4-fluorofenilo)-2-tienilometilo]benzeno
CA2777528C (en) * 2009-10-14 2018-09-18 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
MX339570B (es) 2010-05-11 2016-05-31 Janssen Pharmaceutica Nv Formulaciones farmaceuticas que comprenden derivados de 1-(beta-d-glucopiranosil)-2-tienil-metilbenceno como inhibidores de transportadores de glucosa dependientes de sodio.
EP2697218B1 (en) 2011-04-13 2016-05-25 Janssen Pharmaceutica NV Process for the preparation of compounds useful as inhibitors of sglt2
US9035044B2 (en) 2011-05-09 2015-05-19 Janssen Pharmaceutica Nv L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
CN112279820B (zh) * 2020-12-18 2021-04-02 苏州开元民生科技股份有限公司 2-(4-甲氧苯基)-3-羟基-2,3-二氢-1,5-苯并硫氮杂卓酮的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025983A (ja) * 1983-07-22 1985-02-08 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体
JPS6025982A (ja) * 1983-07-22 1985-02-08 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体の製法
FI95931C (fi) * 1988-09-02 1996-04-10 Tanabe Seiyaku Co Menetelmä (2R,3S)-3-(4-metoksifenyyli)glysidiinihapon alemman alkyyliesterin valmistamiseksi
IT1237526B (it) * 1989-12-06 1993-06-08 Zambon Spa Processo di preparazione di un intermedio per il diltiazem
JPH0486727A (ja) * 1990-07-31 1992-03-19 Toshiba Corp 光増幅装置
JP2788385B2 (ja) * 1991-12-05 1998-08-20 田辺製薬株式会社 酵素反応による光学活性ベンゾチアゼピン類の製造法

Also Published As

Publication number Publication date
ID18081A (id) 1998-02-26
KR19980019025A (ko) 1998-06-05
EP0826678A1 (en) 1998-03-04
CN1174837A (zh) 1998-03-04
US5945533A (en) 1999-08-31

Similar Documents

Publication Publication Date Title
HUP0500044A3 (en) Process for prepare oxazolidinones
GB9510757D0 (en) Therapeuticaly active compounds
AU1956497A (en) Decontamination process
GB2307687B (en) Fibres
TW342707U (en) Incubator
GB9522721D0 (en) Incubator
ZA977493B (en) Optically active compounds
IL121525A0 (en) Process for preparing optically active benzothiazepine compound and intermediate therefor
GB9415232D0 (en) Rotating incubator
TW365161U (en) Incubator
AU3855995A (en) Optically active compound
HUP9802146A3 (en) Process for preparing optically active 2-amino-omega-oxoalkanoic acid derivatives and the compounds
AU3391895A (en) Supports
HUP0000807A2 (en) Process for the preparation of optically active n-benzyl-3-pyrrolidinol
HUP9903874A3 (en) Optically active erythro-3-amino-2-hydroxybutyric esters and process for preparing said esters
SG72731A1 (en) Process for preparing optically active trans-3-phenylglycidamide compounds
GB9407484D0 (en) Enzyme
EP0943689A4 (en) METHOD FOR PRODUCING FR900482 AND ANALOG CONNECTIONS
GB9521167D0 (en) Enzyme
GB9424232D0 (en) Growth factor expression
HUP9601362A3 (en) Process for producing optically active compounds
IL119632A0 (en) Process for preparing optically active 3-hydroxy-1,5-benzothiazepine derivatives and intermediates therefor
GB9513275D0 (en) Patient support
HUP9601361A3 (en) Process for producing optically active compounds
HUT75454A (en) Concentrated solutions for hemodialysing